NF1 and malignant peripheral nerve sheath tumor: Based on these data, we hypothesized that in NF1-deficient MPNST, vertical inhibition of ERK signaling by pan-RAFi plus MEKi would enhance the efficacy of single-agent MEKi through partially overcoming both the adaptive and acquired resistance to MEKi.